newsroom

	2012, June	OxThera Resumes Clinical Development of Hyperoxaluria Therapy
	2008, April	Pivotal study is being conducted with Oxabact™ for the treatment of Primary Hyperoxaluria
	2007, November	OxThera Raises SEK 24 Million in New Round of Financing
	2007, June	OxThera Raises SEK 150 Million in New Round of Financing
	2005, July	External Financing of SEK 165 Million Secured For Q-Med's Oxalate Project